Current and historical daily PE Ratio for Dishman Carbogen Amics Ltd (
) from 2004 to Jun 08 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Dishman Carbogen Amics stock (NSE:DCAL) PE ratio as of Jun 08 2024 is 0.
More Details
Dishman Carbogen Amics Ltd (NSE:DCAL) PE Ratio (TTM) Chart
Dishman Carbogen Amics Ltd (NSE:DCAL) PE Ratio (TTM) Historical Data
View and export this data going back to 2004. Start your Free Trial
Total 1296
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| Dishman Carbogen Amics PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-08 | At Loss | 2024-04-09 | At Loss |
| 2024-06-07 | At Loss | 2024-04-08 | At Loss |
| 2024-06-06 | At Loss | 2024-04-05 | At Loss |
| 2024-06-05 | At Loss | 2024-04-04 | At Loss |
| 2024-06-04 | At Loss | 2024-04-03 | At Loss |
| 2024-06-03 | At Loss | 2024-04-02 | At Loss |
| 2024-05-31 | At Loss | 2024-04-01 | At Loss |
| 2024-05-30 | At Loss | 2024-03-29 | At Loss |
| 2024-05-29 | At Loss | 2024-03-28 | At Loss |
| 2024-05-28 | At Loss | 2024-03-27 | At Loss |
| 2024-05-27 | At Loss | 2024-03-26 | At Loss |
| 2024-05-24 | At Loss | 2024-03-25 | At Loss |
| 2024-05-23 | At Loss | 2024-03-22 | At Loss |
| 2024-05-22 | At Loss | 2024-03-21 | At Loss |
| 2024-05-21 | At Loss | 2024-03-20 | At Loss |
| 2024-05-20 | At Loss | 2024-03-19 | At Loss |
| 2024-05-18 | At Loss | 2024-03-18 | At Loss |
| 2024-05-17 | At Loss | 2024-03-15 | At Loss |
| 2024-05-16 | At Loss | 2024-03-14 | At Loss |
| 2024-05-15 | At Loss | 2024-03-13 | At Loss |
| 2024-05-14 | At Loss | 2024-03-12 | At Loss |
| 2024-05-13 | At Loss | 2024-03-11 | At Loss |
| 2024-05-10 | At Loss | 2024-03-08 | At Loss |
| 2024-05-09 | At Loss | 2024-03-07 | At Loss |
| 2024-05-08 | At Loss | 2024-03-06 | At Loss |
| 2024-05-07 | At Loss | 2024-03-05 | At Loss |
| 2024-05-06 | At Loss | 2024-03-04 | At Loss |
| 2024-05-03 | At Loss | 2024-03-01 | At Loss |
| 2024-05-02 | At Loss | 2024-02-29 | At Loss |
| 2024-05-01 | At Loss | 2024-02-28 | At Loss |
| 2024-04-30 | At Loss | 2024-02-27 | At Loss |
| 2024-04-29 | At Loss | 2024-02-26 | At Loss |
| 2024-04-26 | At Loss | 2024-02-23 | At Loss |
| 2024-04-25 | At Loss | 2024-02-22 | At Loss |
| 2024-04-24 | At Loss | 2024-02-21 | At Loss |
| 2024-04-23 | At Loss | 2024-02-20 | At Loss |
| 2024-04-22 | At Loss | 2024-02-19 | At Loss |
| 2024-04-19 | At Loss | 2024-02-16 | At Loss |
| 2024-04-18 | At Loss | 2024-02-15 | At Loss |
| 2024-04-17 | At Loss | 2024-02-14 | At Loss |
| 2024-04-16 | At Loss | 2024-02-13 | At Loss |
| 2024-04-15 | At Loss | 2024-02-12 | At Loss |
| 2024-04-12 | At Loss | 2024-02-09 | At Loss |
| 2024-04-11 | At Loss | 2024-02-08 | At Loss |
| 2024-04-10 | At Loss | 2024-02-07 | At Loss |
Dishman Carbogen Amics Ltd (NSE:DCAL) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Dishman Carbogen Amics Ltd
ISIN : INE385W01011
Compare
Compare
Traded in other countries / regions
DCAL.India IPO Date
2004-04-22Description
Dishman Carbogen Amics Ltd is a biotechnology company that provides contract research and manufacturing services for pharmaceutical companies. It manufactures bulk drugs, specialty chemicals, and outsourced goods. Additionally, the company produces vitamins, such as vitamin D2 and vitamin D3, reagents, antiseptics and disinfectants, transfer catalysts, personal-care ingredients, pharma intermediates, and ammonium and phosphonium high-purity solid Quats. The business generates the vast majority of its revenue in India.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers